WB4792R
This course reviews syphilis screening, how to interpret results and stage disease, and syphilis treatment recommendations based on stage of disease.
At the conclusion of the session, the participant should be able to:
- Describe the diagnostic considerations for syphilis.
- Describe how to treat syphilis.
- Describe the importance of interprofessional collaboration in screening for and treating syphilis.
FACULTY/CREDENTIALS:
Alexandra Filipkowski, MPH, Intern, New York City STI/HIV Prevention Training Center
Natalie Neu, MD, MPH, Medical Director, NYC STI/HIV Prevention Training Center; Associate Professor of Pediatrics, Columbia University Medical Center
Jessica Steinke, MPH, Senior Program Manager, New York City STI/HIV Prevention Training Center
Jason Zucker, MD, MS, Assistant Medical Director, New York City STI/HIV Prevention Training Center; Assistant Professor, Divisions of Adult and Pediatric Infectious Diseases, Columbia University Medical Center
CE ORIGINATION DATE: April 1, 2024
CE RENEWAL DATE: April 1, 2026
CE EXPIRATION DATE: April 1, 2028
TARGET AUDIENCE: Physicians, Nurse Practitioners, Physician Assistants, Registered Nurses, and other healthcare professionals
PREREQUISITES: Intended for clinicians who provide clinical care for patients with STIs.
FORMAT: This activity is Web-based.
CONTACT INFORMATION: NYC STI/HIV Prevention Training Center, nycptc@cumc.columbia.edu
ACCREDITATION STATEMENTS:
|
|
In support of improving patient care, this activity has been planned and implemented by Centers for Disease Control and Prevention and The NYC STI/HIV Prevention Training Center. The Centers for Disease Control and Prevention is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
|
CME: The Centers for Disease Control and Prevention designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE: The Centers for Disease Control and Prevention designates this activity for 0.75 nursing contact hours.
CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 0.1 CEU's for this program.
DISCLOSURE:
In compliance with continuing education requirements, all planners and presenters must disclose all financial relationships, in any amount, with ineligible companies during the previous 24 months as well as any use of unlabeled product(s) or products under investigational use.
CDC, our planners and content experts wish to disclose they have no financial relationship(s) with ineligible companies with the exception of Dr. Neu. Dr. Neu wishes to disclose that she is a DSMB member for Melinta Pharmaceuticals and Cystic Fibrosis Foundation and receives a consulting fee from 2nd.MD. All relevant financial relationships listed for this individual has been mitigated.
Content will not include any discussion of the unlabeled use of a product or a product under investigational use.
CDC did not accept financial or in-kind support from ineligible companies for this continuing education activity.
The Centers for Disease Control and Prevention (CDC) complies with applicable Federal civil rights laws and does not discriminate based on race, color, national origin, age, disability, religion, or sex. To learn more visit https://www.hhs.gov/civil-rights/for-individuals/nondiscrimination/index.html.
Instructions for Obtaining Continuing Education (CE)
To receive continuing education (CE) for WB4792R – We're Still Talking About Syphilis!, please visit CDC TRAIN and search for the course in the Course Catalog using WB4792R. Follow the steps below by April 1, 2028.
- Register for and complete the course.
- Pass the post-assessment at 75%.
- Complete the evaluation.
- Visit Your Learning to access your certificates and transcript.
FEES: No fees are charged for CDC’s CE activities.
Grant Statement:
This project is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award 1 NU62PS924586-01-00 totaling $470,000 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.